R J Rangel
Overview
Explore the profile of R J Rangel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leppik I, Boucher B, Wilder B, Murthy V, Watridge C, Graves N, et al.
Neurology
. 1990 Mar;
40(3 Pt 1):456-60.
PMID: 2314588
ACC-9653, a prodrug of phenytoin synthesized to be water soluble, is converted to phenytoin by phosphatases. In this study, 43 patients received ACC-9653 IV or IM. Side effects were transient...
2.
Leppik I, Boucher R, Wilder B, Murthy V, Rask C, Watridge C, et al.
Epilepsia
. 1989 Jan;
30 Suppl 2:S22-6.
PMID: 2670535
The currently available phenytoin (PHT) solution has many disadvantages stemming from poor aqueous solubility of PHT. A novel approach to solve the problem has been the synthesis of a phosphate...
3.
Hammond E, Rangel R, Wilder B
Br J Clin Pract Suppl
. 1988 Mar;
61:16-23.
PMID: 3145771
No abstract available.
4.
Wilder B, Rangel R
Am J Med
. 1988 Jan;
84(1A):7-13.
PMID: 3146225
Well-controlled prospective studies have shown the benefits of converting treatment for patients with epilepsy from polytherapy to monotherapy. Results of trials with valproate have demonstrated its efficacy as monotherapy in...